United Kingdom (UK) Cell And Gene Therapy CDMO Market (2025-2031) | Size & Revenue, Trends, Growth, Forecast, Share, Segmentation, Competitive Landscape, Companies, Outlook, Industry, Analysis, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Cell And Gene Therapy CDMO Market - Industry Life Cycle

3.4 United Kingdom (UK) Cell And Gene Therapy CDMO Market - Porter's Five Forces

3.5 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.6 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in cell and gene therapy research and development in the UK

4.2.2 Favorable regulatory environment supporting the growth of cell and gene therapy CDMO market

4.2.3 Rising prevalence of genetic disorders driving the demand for cell and gene therapy services

4.3 Market Restraints

4.3.1 High cost of cell and gene therapy treatments limiting market adoption

4.3.2 Complex manufacturing processes and technical challenges in cell and gene therapy production

6.1 United Kingdom (UK) Cell And Gene Therapy CDMO Market, By Phase

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F

6.1.3 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F

6.1.4 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.2 United Kingdom (UK) Cell And Gene Therapy CDMO Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.3 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F

6.2.4 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.3 United Kingdom (UK) Cell And Gene Therapy CDMO Market, By Indication

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.4 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F

6.3.5 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F

6.3.6 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) Cell And Gene Therapy CDMO Market Export to Major Countries

7.2 United Kingdom (UK) Cell And Gene Therapy CDMO Market Imports from Major Countries

8.1 Number of partnerships and collaborations between UK cell and gene therapy CDMOs and biopharmaceutical companies

8.2 Success rate of clinical trials for cell and gene therapy products in the UK

8.3 Number of patents filed for cell and gene therapy technologies in the UK

9.1 United Kingdom (UK) Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F

9.2 United Kingdom (UK) Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 United Kingdom (UK) Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 United Kingdom (UK) Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters